Literature DB >> 30466527

Switching, Discontinuation, and Reinitiation of Statins Among Older Adults.

Richard Ofori-Asenso, Jenni Ilomaki, Mark Tacey, Ella Zomer, Andrea J Curtis, Si Si, Andrew R Zullo, Maarit Jaana Korhonen, J Simon Bell, Sophia Zoungas, Danny Liew.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 30466527      PMCID： PMC8915196          DOI： 10.1016/j.jacc.2018.08.2191

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN： 0735-1097            Impact factor:   24.094


× No keyword cloud information.
  3 in total

1.  Construction and characteristics of the RxRisk-V: a VA-adapted pharmacy-based case-mix instrument.

Authors:  Kevin L Sloan; Anne E Sales; Chuan-Fen Liu; Paul Fishman; Paul Nichol; Norman T Suzuki; Nancy D Sharp
Journal:  Med Care       Date:  2003-06       Impact factor: 2.983

Review 2.  When compliance is an issue-how to enhance statin adherence and address adverse effects.

Authors:  Kim Birtcher
Journal:  Curr Atheroscler Rep       Date:  2015-01       Impact factor: 5.113

3.  The Australian Pharmaceutical Benefits Scheme data collection: a practical guide for researchers.

Authors:  Leigh Mellish; Emily A Karanges; Melisa J Litchfield; Andrea L Schaffer; Bianca Blanch; Benjamin J Daniels; Alicia Segrave; Sallie-Anne Pearson
Journal:  BMC Res Notes       Date:  2015-11-02
  3 in total
  7 in total

Review 1.  PCSK9 Antibody-based Treatment Strategies for Patients With Statin Intolerance.

Authors:  Errika Voutyritsa; Christos Damaskos; Paraskevi Farmaki; Georgios Kyriakos; Evangelos Diamantis; Lourdes Victoria Quiles-SÁnchez; Anna Garmpi; Nikolaos Garmpis; Alexandros Patsouras; Athanasia Stelianidi; Spyridon Savvanis
Journal:  In Vivo       Date:  2021 Jan-Feb       Impact factor: 2.155

2.  Patient-Associated Characteristics Influencing the Risk for Non-Persistence with Statins in Older Patients with Peripheral Arterial Disease.

Authors:  Martin Wawruch; Gejza Wimmer; Jan Murin; Martina Paduchova; Tomas Tesar; Lubica Hlinkova; Peter Slavkovsky; Lubomira Fabryova; Emma Aarnio
Journal:  Drugs Aging       Date:  2019-09       Impact factor: 3.923

3.  Factors Associated with Reinitiation of Statin Treatment in Older Patients with Peripheral Arterial Disease.

Authors:  Martin Wawruch; Gejza Wimmer; Jan Murin; Martina Paduchova; Tomas Tesar; Lubica Hlinkova; Peter Slavkovsky; Emma Aarnio
Journal:  Drugs Aging       Date:  2020-08       Impact factor: 3.923

4.  Effect of alirocumab on cardiovascular outcomes after acute coronary syndromes according to age: an ODYSSEY OUTCOMES trial analysis.

Authors:  Peter R Sinnaeve; Gregory G Schwartz; Daniel M Wojdyla; Marco Alings; Deepak L Bhatt; Vera A Bittner; Chern-En Chiang; Roger M Correa Flores; Rafael Diaz; Maria Dorobantu; Shaun G Goodman; J Wouter Jukema; Yong-Un Kim; Robert Pordy; Matthew T Roe; Rody G Sy; Michael Szarek; Harvey D White; Andreas M Zeiher; Ph Gabriel Steg
Journal:  Eur Heart J       Date:  2020-06-21       Impact factor: 29.983

Review 5.  Determinants of Non-Adherence to the Medications for Dyslipidemia: A Systematic Review.

Authors:  João Lopes; Paulo Santos
Journal:  Patient Prefer Adherence       Date:  2021-08-24       Impact factor: 2.711

6.  Patient-Reported Reasons for Switching or Discontinuing Statin Therapy: A Mixed Methods Study Using Social Media.

Authors:  Su Golder; Davy Weissenbacher; Karen O'Connor; Sean Hennessy; Robert Gross; Graciela Gonzalez Hernandez
Journal:  Drug Saf       Date:  2022-08-07       Impact factor: 5.228

7.  Switching, Persistence and Adherence to Statin Therapy: a Retrospective Cohort Study Using the Australian National Pharmacy Data.

Authors:  Stella Talic; Clara Marquina; Richard Ofori-Asenso; Marjana Petrova; Danny Liew; Alice J Owen; Sean Lybrand; David Thomson; Jenni Ilomaki; Ella Zomer; Zanfina Ademi
Journal:  Cardiovasc Drugs Ther       Date:  2021-06-07       Impact factor: 3.947
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.